With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

Patenting generative AI technologies presents challenges, particularly in defining AI’s role in the invention process. A key ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...